Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs MasTec Inc (MTZ) Price & Performance

Abeona Therapeutics IncTrade
MasTec IncTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs MasTec Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while MasTec Inc trades at $280.2 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 52× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.

ABEOMTZ
Market Cap
$421.19M$21.90B
Sector
HealthTechnology
52-Week High
$7.45$437.51
52-Week Low
$4.17$172.51
Enterprise Value
$276.10M$24.81B

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

Read more on MTZ